Regeneron Says It Has A 'Paradigm-Shifting' Cancer Drug; Can It Takes On J&J?

Core Insights - Regeneron has announced "paradigm-shifting" test results for a new drug aimed at preventing the development of multiple myeloma [1] Company Summary - The drug developed by Regeneron is positioned as a significant advancement in the treatment landscape for multiple myeloma, potentially altering the standard of care [1]